#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

Malobuněčný karcinom plic

Options for Systemic Therapy of Advanced Stage Small Cell Lung Cancer

22. 2. 2024 Source: Small Cell Lung Cancer

Small cell lung cancer (SCLC) is the most aggressive type of lung tumor. Although it responds well to chemotherapy and radiotherapy, due to the early onset of treatment resistance, the 5-year survival rate is less than 10%. After more than 30 years of very limited progress in treating advanced SCLC patients, immune checkpoint inhibitors (checkpoints) have been introduced to the market, significantly prolonging survival. What are the current recommendations for treating patients with advanced SCLC?

Karcinom prsu

Current Sequence of Treatment for Metastatic HER2+ Breast Cancer

In September 2023, experts from Miami Cancer Institute published their consensus statement on the…
22. 2. 2024 Source: Ovarian and Breast Cancer
Oko AI

Artificial Intelligence and Deep Learning as the Future of Glaucoma Diagnosis

Glaucoma represents a group of eye diseases characterized by changes to the optic nerve. It is the…
21. 2. 2024 Source: medScope.pro
MUDr. Zárubová FOTO

MUDr. Jana Zárubová: Experiences with buccal midazolam in real practice are positive and we can significantly improve patients' quality of life

Recently, it has emerged as an alternative to traditionally rectally administered diazepam for…
21. 2. 2024 Source: Quick aid for acute convulsive seizures in children and adolescents
Epilepsie_žena

IEC 2023: Key Challenges for Epilepsy Patients Include Status Epilepticus and Anxiety Management

Why is anxiety a significant issue for epilepsy patients? What do current insights say about the…
21. 2. 2024 Source: Quick aid for acute convulsive seizures in children and adolescents
MOZOG NEURON

Ocrelizumab in the Treatment of Multiple Sclerosis – 10-Year Data

Multiple sclerosis (MS) is a lifelong disease with a high risk of permanent disability. Current…
20. 2. 2024 Source: Neurology - Multiple Sclerosis
symptomatická léčba

Long-term Efficacy and Safety of Mavacamten in the Treatment of Obstructive HCM

Interim results of the MAVA-LTE study provide the latest data on the long-term safety and efficacy…
19. 2. 2024 Source: Hypertrophic Cardiomyopathy (HCM)
farmakoterapie

Mavacamten in the Treatment of HCM in Patients Referred for Septal Reduction

Extended 56-week follow-up of patients with hypertrophic cardiomyopathy (HCM) resistant to current…
19. 2. 2024 Source: Hypertrophic Cardiomyopathy (HCM)
starší muž aktivita

How Does Myelodysplastic Syndrome Affect Patients' Quality of Life?

Myelodysplastic syndrome (MDS) is a heterogeneous group of disorders of hematopoietic stem cells…
15. 2. 2024 Source: Myelodysplastic Syndrome (MDS)
3D tisk

Planning Surgery Using 3D Printing in Practice – Case Study

In October 2023, an article by neurosurgeons from Leipzig University was published in the journal …
25. 1. 2024 Source: medScope.pro
1 14 15 16 17 18 162
Filter by speciality
Remove filters

Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#